Yubo International Biotech Limited(YBGJ.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Yubo International Biotech Limited
YBGJ.US
Yubo International Biotech Limited, through its subsidiaries, focuses on the research, development, and application of endometrial stem cells. The company offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. Yubo International Biotech Limited is headquartered in Beijing, China.
1.927 T
YBGJ.USMarket value -Rank by Market Cap -/-

Financial Score

22/01/2026 Update
D
BiotechnologyIndustry
Industry Ranking336/398
Industry medianC
Industry averageD
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE46.21%A
    • Profit Margin6152688.89%A
    • Gross Margin0.00%E
  • Growth ScoreD
    • Revenue YoY-100.07%E
    • Net Profit YoY44.71%B
    • Total Assets YoY-42.37%E
    • Net Assets YoY47.33%A
  • Cash ScoreD
    • Cash Flow Margin0.00%C
    • OCF YoY-100.07%E
  • Operating ScoreE
    • Turnover0E
  • Debt ScoreE
    • Gearing Ratio268.07%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    ProImmune Introduces Mastering Immunity 2026 - Shanghai Symposium to Address Key Immunogenicity Challenges

    ProImmune Ltd has announced the Mastering Immunity 2026 symposium, set for April 13-14, 2026, at the Oriental Riverside Hotel in Shanghai. This inaugural event will focus on immunogenicity challenges in drug development, featuring global leaders in biotherapeutics and regulatory authorities. The symposium aims to provide practical guidance for managing immunogenicity risks, which can significantly impact the success of drug programs. Notable speakers include experts from the FDA, Pfizer, and Roche. The event is positioned as essential for those involved in the biopharmaceutical industry in China.

    MorningStar·
    MorningStar·

    U.S. Stock Movement Update: Anteris Tech surges 41.74%, Corvus Pharma drops 10.09% attracting attention

    In the past hour, the overall market in the U.S. stock market has shown a clear divergence, with technology stocks and the biopharmaceutical sector performing particularly well. The strong rise of Anteris Tech Global has attracted a significant inflow of funds, while Corvus Pharma has faced notable selling pressure, indicating a polarization of market sentiment. Short-term enthusiasm has increased among small-cap stocks, especially with active performances from individual stocks like Moolec Science and Senmiao Tech, driving fluctuations in related sectors. Overall, the market pace is relatively fast, with funds frequently switching between different themes, leading to increased volatility. The stock with the largest movement in the past hour, Anteris Tech Global, surged by 41.74%, becoming the market's focal point. The stock quickly rose after the opening, attracting a large amount of short-term funds, with sentiment high, seemingly indicating an optimistic outlook for its future prospects. Strong stocks include: 1. Moolec Science SA: up 9.11%, driven by recent market expectations for its new products, with active short-term funds. 2. Senmiao Tech: up 7.75%, performing well against the backdrop of an overall recovery in technology stocks, attracting considerable investor attention. 3. Rezolve AI: up 7.61%, with the company's recent technological advancements igniting market enthusiasm and noticeable fund inflows

    Tracking Unusual Activity·
    US
    BIDU
    +8.17%
    Tracking Unusual Activity·
    US
    BIDU
    +8.17%

    In the Hong Kong stock market, the Hang Seng Index fell 39 points in the first half of the day, Anta dropped over 5%, and SMIC HUA HONG SEMI rose

    The Hong Kong stock market opened softly, with the Hang Seng Index down 39 points at 26,447 points. The National Index fell 24 points, while the Hang Seng Tech Index rose 8 points. The total turnover was HKD 127.653 billion. Anta dropped over 5%, while SMIC rose 4.7%. Baidu's stock price increased by 3.3% due to a target price adjustment. Technology stocks showed mixed performance, with Tencent slightly down 0.2% and Alibaba up 1.1%. In the automotive sector, BYD rose 1.1%

    AASTOCKS·
    HK
    01347
    +2.93%
    HK
    00HSI
    -0.07%
    HK
    09888
    +3.58%
    AASTOCKS·
    HK
    01347
    +2.93%
    HK
    00HSI
    -0.07%
    HK
    09888
    +3.58%

    Bain makes binding FineToday bid, eyes Asia beauty market: sources

    Bain Capital has made a binding offer for FineToday Holdings, a Japanese personal-care group, aiming to expand in Asia's beauty market. Competitors KKR and Blackstone have withdrawn from the bidding. FineToday, known for brands like Tsubaki shampoo, operates in 11 Asian markets, with China being a significant market. The company previously attempted an IPO but faced valuation issues. Japan's deal-making reached a record high in 2025, driven by corporate governance reforms and private equity interest.

    Businesstimes News·
    Businesstimes News·

    The Hang Seng Index closed down 0.29%, and the Hang Seng TECH Index fell 1.16%

    36Kr learned that the Hang Seng Index closed down 0.29%, and the Hang Seng Tech Index fell 1.16%; new consumption, non-ferrous metals, and building materials sectors led the gains, with Pop Mart rising over 9% and Mao Geping rising over 4%. CHIFENG GOLD rose over 3%, and WESTCHINACEMENT rose over 2%; hardware equipment, automotive, and semiconductor sectors led the declines, with PANASIALUM falling over 14%, BYD Company falling over 3%, and Innovent falling over 2%; southbound funds had a net purchase of HKD 3.663 billion

    36Kr·
    36Kr·
    © 2026 Longbridge｜Disclaimer